-transparent.png){kind=logo}
Dendritic cells (DC) are potent APCs. In this study, murine bone marrow-derived DC were transfected with RNA encoding the MUC1 Ag that is aberrantly overexpressed in human breast and other carcinomas. The MUC1 RNA-transfected DC exhibited cell surface expression of MUC1 and costimulatory molecules. After injection at the base of the tail, the transfected DC were detectable in inguinal lymph nodes by dual immunochemical staining. Vaccination of wild-type mice with MUC1 RNA-transfected DC induced anti-MUC1 immune responses against MUC1-positive MC38/MUC1, but not MUC1-negative, tumor cells. Mice immunized with the transfected DC were protected against challenge with MC38/MUC1 tumor cells. Furthermore, mice with established MC38/MUC1 tumors were eliminated after receiving the vaccination. CTLs isolated from mice immunized with the transfected DC exhibited specific cytolytic activity against MC38/MUC1 tumor cells. In contrast to these findings, there was little if any anti-MUC1 immunity induced with the transfected DC in MUC1 transgenic (MUC1.Tg) mice. However, coadministration of the transfected DC and IL-12 reversed the unresponsiveness to MUC1 Ag in MUC1.Tg mice and induced MUC1-specific immune responses. These findings demonstrate that vaccination of DC transfected with MUC1 RNA and IL-12 reverses tolerance to MUC1 and induces immunity against MUC1-positive tumors.
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
November 2001,
Clinical immunology (Orlando, Fla.),
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
September 2000,
Gene therapy,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
September 2010,
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
March 2003,
Cancer gene therapy,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
December 2002,
Expert review of vaccines,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
October 2003,
The Journal of investigative dermatology,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
October 1997,
Gene therapy,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
January 2020,
Pharmaceutics,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
November 2010,
Cellular & molecular immunology,
S Koido, and
M Kashiwaba, and
D Chen, and
S Gendler, and
D Kufe, and
J Gong
February 2000,
Cancer research,
